Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-stage Prospective Observational Cohort Study in Scleroderma Patients to Evaluate Screening Tests and the Incidence of Pulmonary Arterial Hypertension and Pulmonary Hypertension

NCT00706082 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00706082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00706082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-stage Prospective Observational Cohort Study in Scleroderma Patients to Evaluate Screening Tests and the Incidence of Pulmonary Arterial Hypertension and Pulmonary Hypertension
Lead sponsor
Actelion
Phase
Observational
Overall status
Terminated
Start date
October 31, 2008
Completion date
March 31, 2012
Enrollment
490 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension, pulmonary hypertension, systemic sclerosis